NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT02108366 2019-10-21Treatment of Severe Influenza A InfectionThe University of Hong KongPhase 3 Completed107 enrolled
NCT00093678 2015-10-08Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT00357500 2014-10-01Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive CancerDana-Farber Cancer InstitutePhase 2 Completed101 enrolled 10 charts